Dual Antifungal and Antiproliferative Activities of a Novel Protein Fraction from a Medicinally Important Herb Trillium govanianum Wall. ex. D. Don
Applied Biochemistry and Biotechnology · 2024-08 · 196 (8) · 5080-5098
DOI: 10.1007/s12010-023-04786-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Biochemistry and Biotechnology, online erschienen am 01.12.2023. Verfasst von Snober S Wani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, University of Kashmir, Srinagar, Jammu and Kashmir, India, 190006. Hauptthemen laut MEDLINE: Antifungal Agents, Cell Proliferation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Central Council for Research in Homeopathy, Ministry of AYUSH, Government of India.
Abstract (Originalsprache)
Antimicrobial resistance of microorganisms and the unwanted side effects of chemoradiation therapy in cancer are major issues in healthcare. In recent times, protein-based drugs have emerged as promising candidates due to their high specificity, less side effects, etc. In this context, the rhizome of Trillium govanianum was first explored for biologically active proteins/peptides. For this, three protein fractions namely Aqueous protein fraction (APF), Hexane-Methanol-treated aqueous protein fraction (HMAPF), and Methanol-treated aqueous protein fraction (MAPF) were prepared and evaluated for antimicrobial and antiproliferative activities. In antifungal activity, HMAPF showed the lowest MIC90 values of 1.56 µg/ml against Candida parapsilosis and Candida glabrata and 3.12 µg/ml against Candida albicans and Candida auris. The antifungal activity was further confirmed by a chitinase assay, a growth kinetics and a proteinase inhibitory assay. Surprisingly, none of the three protein fractions exhibited antibacterial activity against Escherichia coli and Staphylococcus aureus. Moreover, APF exhibited potent antiproliferative and antioxidant activities with IC50 values of 18 µg/ml and 227 µg /ml, respectively. For HMAPF, an IC50 value of 70 µg/ml against the MDA-MB-231 cell line was observed. The present results demonstrate that the protein fractions, particularly HMAPF and APF, might serve as potential sources of a dual antifungal and antiproliferative protein-based drug.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Biochemistry, University of Kashmir, Srinagar, Jammu and Kashmir, India, 190006.
- Department of Bioresources, University of Kashmir, Srinagar, Jammu and Kashmir, India, 190006.
- Department of Bioresources, University of Kashmir, Srinagar, Jammu and Kashmir, India, 190006. abdulhaseeb@kashmiruniversity.ac.in.
- Department of Clinical Biochemistry, University of Kashmir, Srinagar, Jammu and Kashmir, India, 190006. tanveerali@kashmiruniversity.ac.in.
Förderung
- Central Council for Research in Homeopathy, Ministry of AYUSH, Government of India
Zitieren
APA
Wani, S. S., Qadri, H., Shah, A. H., & Dar, T. A. (2024). Dual Antifungal and Antiproliferative Activities of a Novel Protein Fraction from a Medicinally Important Herb Trillium govanianum Wall. ex. D. Don. Applied Biochemistry and Biotechnology, 196(8), 5080-5098. https://doi.org/10.1007/s12010-023-04786-2
Vancouver
Wani SS, Qadri H, Shah AH, Dar TA. Dual Antifungal and Antiproliferative Activities of a Novel Protein Fraction from a Medicinally Important Herb Trillium govanianum Wall. ex. D. Don. Applied Biochemistry and Biotechnology. 2024;196(8):5080-5098. doi:10.1007/s12010-023-04786-2
BibTeX
@article{Wani2024,
author = {Wani, Snober S and Qadri, Hafsa and Shah, Abdul H and Dar, Tanveer A},
title = {Dual Antifungal and Antiproliferative Activities of a Novel Protein Fraction from a Medicinally Important Herb Trillium govanianum Wall. ex. D. Don},
journal = {Applied Biochemistry and Biotechnology},
year = {2024},
volume = {196},
number = {8},
pages = {5080--5098},
doi = {10.1007/s12010-023-04786-2}
}
EUVIMED